Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Sell
39
EVO Quote, Financials, Valuation and Earnings
Last price:
$4.4600
Seasonality move
:
14056.73%
Day range:
$4.3300 - $4.4800
52-week range:
$2.8500 - $10.0870
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.88x
P/B ratio:
1.46x
Volume:
91.7K
Avg. volume:
203K
1-year change:
-57.56%
Market cap:
$1.6B
Revenue:
$846M
EPS (TTM):
-$0.53
Analysts' Opinion
-
Consensus RatingEvotec SE has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.9761, Evotec SE has an estimated upside of 40.79% from its current price of $4.4600.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.7835 representing 100% downside risk from its current price of $4.4600.
Fair Value
-
According to the consensus of 3 analysts, Evotec SE has 40.79% upside to fair value with a price target of $6.9761 per share.
EVO vs. S&P 500
-
Over the past 5 trading days, Evotec SE has underperformed the S&P 500 by -8.17% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Evotec SE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Evotec SE revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Evotec SE reported revenues of $203.3M.
Earnings Growth
-
Evotec SE has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Evotec SE reported earnings per share of -$0.12.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
1.88x
EV / EBIT:
--
EV / Revenue:
2.00x
PEG ratio (5yr expected):
-0.10x
EV / Free cash flow:
-7.38x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$115.4M
Return On Assets:
-7.98%
Net Income Margin (TTM):
-22.02%
Return On Equity:
-15.99%
Return On Invested Capital:
-10.76%
Operating Margin:
-17.68%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $757.3M | $874.9M | $843M | $213.7M | $203.3M | |
| Gross Profit | $157.3M | $233.2M | $115.4M | $41.2M | $20.1M | |
| Operating Income | -$34.6K | $4.7M | -$107.2M | -$13.3M | -$36M | |
| EBITDA | -$152M | -$67.8M | -$207.7M | -$28.7M | -$49.5M | |
| Diluted EPS | -$0.57 | -$0.28 | -$0.53 | -$0.12 | -$0.12 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $501.5M | $728.8M | $1.1B | $994.1M | $779.7M | |
| Total Assets | $1.4B | $2.1B | $2.2B | $2.4B | $2.2B | |
| Current Liabilities | $228.8M | $294.4M | $335M | $459.4M | $372.6M | |
| Total Liabilities | $818.2M | $899.1M | $1B | $1.2B | $1.1B | |
| Total Equity | $555.1M | $1.2B | $1.2B | $1.2B | $1.1B | |
| Total Debt | $407M | $409.4M | $321.4M | $623.2M | $525M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $315.2M | -$3.4M | -$40.1M | $25.9M | $44.6M | |
| Cash From Investing | -$552.5M | $21.1M | -$129.5M | -$19.7M | -$29.9M | |
| Cash From Financing | $422.6M | $42.7M | -$120.6M | $46.4M | -$10.8M | |
| Free Cash Flow | $134.2M | -$199.5M | -$228.5M | -$24M | $11.6M | |
EVO
Sector
Market Cap
$1.6B
$49.2M
Price % of 52-Week High
44.22%
48.57%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-57.56%
-30.94%
Beta (5-Year)
1.441
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$4.5138
200-day SMA
Sell
Level
$4.6851
Bollinger Bands (100)
Buy
Level
3.258 - 4.618
Chaikin Money Flow
Sell
Level
-60.6M
20-day SMA
Sell
Level
$4.5623
Relative Strength Index (RSI14)
Sell
Level
48.6333
ADX Line
Sell
Level
10.3135
Williams %R
Neutral
Level
-67.3684
50-day SMA
Sell
Level
$4.5182
MACD (12, 26)
Sell
Level
-0.0424
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
16.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1708)
Sell
CA Score
(Annual)
Level (-0.415)
Buy
Beneish M-Score
(Annual)
Level (-3.087)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.6887)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Stock Forecast FAQ
In the current month, EVO has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The EVO average analyst price target in the past 3 months is $6.9761.
-
Where Will Evotec SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that Evotec SE share price will rise to $6.9761 per share over the next 12 months.
-
What Do Analysts Say About Evotec SE?
Analysts are divided on their view about Evotec SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evotec SE is a Sell and believe this share price will drop from its current level to $3.7835.
-
What Is Evotec SE's Price Target?
The price target for Evotec SE over the next 1-year time period is forecast to be $6.9761 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is EVO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Evotec SE is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EVO?
You can purchase shares of Evotec SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evotec SE shares.
-
What Is The Evotec SE Share Price Today?
Evotec SE was last trading at $4.4600 per share. This represents the most recent stock quote for Evotec SE. Yesterday, Evotec SE closed at $4.4600 per share.
-
How To Buy Evotec SE Stock Online?
In order to purchase Evotec SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
